Paper35149239
Type I interferons and SARS-CoV-2: from cells to organisms.
Bastard P and 4 others. Curr Opin Immunol, 2022. Cited by 65 papers, by iCite.
Cite this record
ConductScience Library. Type I interferons and SARS-CoV-2: from cells to organisms. Papers, record 35149239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35149239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Interferon Type I | Major topic |
| SARS-CoV-2 | Major topic |
| Animals | |
| Humans |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| UM1 HG006504 | NHGRI NIH HHS | United States | UM1HG006504 | PubMed | NIH RePORTER |
| UL1 TR001866 | NCATS NIH HHS | United States | UL1TR001866 | PubMed | NIH RePORTER |
| S10 OD018521 | NIH HHS | United States | S10OD018521 | PubMed | NIH RePORTER |
| R01 AI088364 | NIAID NIH HHS | United States | R01AI088364 | PubMed | NIH RePORTER |
| R01 AI163029 | NIAID NIH HHS | United States | R01AI163029 | PubMed and NIH | NIH RePORTER |
| U24 HG008956 | NHGRI NIH HHS | United States | U24HG008956 | PubMed | NIH RePORTER |
References130
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32015507 | A pneumonia outbreak associated with a new coronavirus of probable bat origin. | Nature | 2020 | https://conductscience.org/library/papers/32015507 | PubMed |
| 2 | 33976430 | RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells. | Nat Immunol | 2021 | https://conductscience.org/library/papers/33976430 | PubMed |
| 3 | 33890986 | Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. | J Exp Med | 2021 | https://conductscience.org/library/papers/33890986 | PubMed |
| 4 | 34671122 | The type I interferonopathies: 10 years on. | Nat Rev Immunol | 2022 | https://conductscience.org/library/papers/34671122 | PubMed |
| 5 | 34010947 | Diverse functional autoantibodies in patients with COVID-19. | Nature | 2021 | https://conductscience.org/library/papers/34010947 | PubMed |
| 6 | 33170317 | ACE2: The Major Cell Entry Receptor for SARS-CoV-2. | Lung | 2020 | https://conductscience.org/library/papers/33170317 | PubMed |
| 7 | 33031744 | A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice. | Cell | 2020 | https://conductscience.org/library/papers/33031744 | PubMed |
| 8 | 33340034 | Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets. | Nat Microbiol | 2021 | https://conductscience.org/library/papers/33340034 | PubMed |
| 9 | 11514542 | Interferon-kappa, a novel type I interferon expressed in human keratinocytes. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11514542 | PubMed |
| 10 | 34381043 | Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19. | Nat Commun | 2021 | https://conductscience.org/library/papers/34381043 | PubMed |
| 11 | 33997835 | Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. | Lancet Reg Health Eur | 2021 | https://conductscience.org/library/papers/33997835 | PubMed |
| 12 | 32967005 | Animal models for COVID-19. | Nature | 2020 | https://conductscience.org/library/papers/32967005 | PubMed |
| 13 | 34166232 | Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia. | J Clin Invest | 2021 | https://conductscience.org/library/papers/34166232 | PubMed |
| 14 | 32938761 | Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV. | J Virol | 2020 | https://conductscience.org/library/papers/32938761 | PubMed |
| 15 | 34378952 | SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells. | Microbiol Spectr | 2021 | https://conductscience.org/library/papers/34378952 | PubMed |
| 16 | 34370799 | Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/34370799 | PubMed |
| 17 | 33333024 | Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses. | Cell | 2021 | https://conductscience.org/library/papers/33333024 | PubMed |
| 18 | 33357464 | Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors. | Cell Host Microbe | 2021 | https://conductscience.org/library/papers/33357464 | PubMed |
| 19 | 32284615 | The proximal origin of SARS-CoV-2. | Nat Med | 2020 | https://conductscience.org/library/papers/32284615 | PubMed |
| 20 | 33392262 | Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be. | Front Mol Biosci | 2020 | https://conductscience.org/library/papers/33392262 | PubMed |
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42760296 | Genetic research on childhood obesity and asthma: exploring genetic risk factors and biological mechanisms. | Pediatr Res | 2026 | https://conductscience.org/library/papers/42760296 | PubMed |
| 42170947 | Previous COVID-19 Vaccination Modulates Type I Interferon and Natural Killer Cell Responses During SARS-CoV-2 Infection. | J Cell Mol Med | 2026 | https://conductscience.org/library/papers/42170947 | PubMed |
| 42008572 | Entry, replication and innate immunity evasion of BANAL-236, a SARS-CoV-2-related bat virus, in Rhinolophus and human cells. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42008572 | PubMed |
| 41959025 | SARS-CoV-2 virus infection of Peromyscus leucopus demonstrates that infection tolerance is not limited to agents for which deermice are reservoirs. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959025 | PubMed |
| 41756780 | Host-pathogen interaction in community-acquired pneumonia: a focus on the immune response. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/41756780 | PubMed |
| 40554591 | Evolutionary divergence of induced versus constitutive antiviral gene expression levels between primates and rodents. | PLoS Comput Biol | 2025 | https://conductscience.org/library/papers/40554591 | PubMed |
| 40286790 | Nerve- and airway-associated interstitial macrophages mitigate SARS-CoV-2 pathogenesis via type I interferon signaling. | Immunity | 2025 | https://conductscience.org/library/papers/40286790 | PubMed |
| 39737903 | Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages. | Nat Commun | 2024 | https://conductscience.org/library/papers/39737903 | PubMed |
| 39680367 | A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity. | J Exp Med | 2025 | https://conductscience.org/library/papers/39680367 | PubMed |
| 39316623 | A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist. | PLoS Biol | 2024 | https://conductscience.org/library/papers/39316623 | PubMed |
| 39170264 | Exploring the potency of polyphenol-rich blend from Lonicera caerulea var. Kamtschatica sevast., Aronia melanocarpa, and Echinacea purpurea: Promising anti-inflammatory, antioxidant, and antiviral properties. | Heliyon | 2024 | https://conductscience.org/library/papers/39170264 | PubMed |
| 39117824 | COVID-19 Pneumonia and Cytokine Storm Syndrome. | Adv Exp Med Biol | 2024 | https://conductscience.org/library/papers/39117824 | PubMed |
| 39062668 | Pathway-Based Mendelian Randomization for Pre-Infection IL-6 Levels Highlights Its Role in Coronavirus Disease. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/39062668 | PubMed |
| 39029640 | Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South Africa. | Clin Immunol | 2024 | https://conductscience.org/library/papers/39029640 | PubMed |
| 38986133 | The Microbe, the Infection Enigma, and the Host. | Annu Rev Microbiol | 2024 | https://conductscience.org/library/papers/38986133 | PubMed |
| 38964332 | Primary nasal influenza infection rewires tissue-scale memory response dynamics. | Immunity | 2024 | https://conductscience.org/library/papers/38964332 | PubMed |
| 38803494 | Microplastics dysregulate innate immunity in the SARS-CoV-2 infected lung. | Front Immunol | 2024 | https://conductscience.org/library/papers/38803494 | PubMed |
| 38795501 | The antiviral state of the cell: lessons from SARS-CoV-2. | Curr Opin Immunol | 2024 | https://conductscience.org/library/papers/38795501 | PubMed |
| 38734674 | LINC01002 functions as a ceRNA to regulate FRMD8 by sponging miR-4324 for the development of COVID-19. | Virol J | 2024 | https://conductscience.org/library/papers/38734674 | PubMed |
| 38698239 | The ouroboros of autoimmunity. | Nat Immunol | 2024 | https://conductscience.org/library/papers/38698239 | PubMed |
Genes32
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35149239
GET https://conductscience.org/api/papers/v1/35149239/references?page=2